Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B5039 DCG IVSummary: highly potent agonist for group II mGlu receptors
- B7682 GTS 21 dihydrochlorideSummary: nAChRs agonist, novel
- A1038 Amyloid β-Peptide (10-20) (human)Summary: Initiates neurodegeneration in Alzheimer disease
- A1013 Endomorphin-1Summary: Agonist of μopioid receptors,highly potent and selective
- B8029 ARN2966Summary: APP expression modulator
- A1039 Amyloid Beta-peptide (25-35) (human)1 CitationSummary: Functional domain of Aβ
- A1040 Myelin Basic Protein (87-99)Summary: Encephalitogenic peptide
- B4796 Meclofenamate SodiumSummary: dual COX-1/COX-2 inhibitor
- B4873 NitenpyramSummary: nicotinic acetylcholine receptor (AchR) agonist
- B4878 LY2119620Summary: positive allosteric modulator of M2/M4 receptor